Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Napoleone Ferrara

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Nature Reviews. Cancer|October 3, 2002
VEGF and the quest for tumour angiogenesis factorsNapoleone Ferrara
Journal of the National Cancer Institute|October 24, 2017
Microvascular Density as a Predictive Biomarker for Bevacizumab Survival Benefit in Ovarian Cancer: Back to First Principles?Napoleone Ferrara
Translational Vision Science & Technology|March 17, 2016
VEGF and Intraocular Neovascularization: From Discovery to TherapyNapoleone Ferrara
Oncology|November 23, 2005
VEGF as a therapeutic target in cancerNapoleone Ferrara
Nature Medicine|October 9, 2010
Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapyNapoleone Ferrara
EXS|December 25, 2004
The role of VEGF in the regulation of physiological and pathological angiogenesisNapoleone Ferrara
The Oncologist|June 5, 2004
Vascular endothelial growth factor as a target for anticancer therapyNapoleone Ferrara
European Cytokine Network|February 20, 2010
VEGF-A: a critical regulator of blood vessel growthNapoleone Ferrara
Cancer Research|September 3, 2016
Commentary on "Humanization of an Anti-VEGF Monoclonal Antibody for the Therapy of Solid Tumors and Other Disorders"Napoleone Ferrara
Cytokine & Growth Factor Reviews|December 17, 2009
Pathways mediating VEGF-independent tumor angiogenesisNapoleone Ferrara
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Nature Reviews. Cancer|October 3, 2002
VEGF and the quest for tumour angiogenesis factorsNapoleone Ferrara
Journal of the National Cancer Institute|October 24, 2017
Microvascular Density as a Predictive Biomarker for Bevacizumab Survival Benefit in Ovarian Cancer: Back to First Principles?Napoleone Ferrara
Translational Vision Science & Technology|March 17, 2016
VEGF and Intraocular Neovascularization: From Discovery to TherapyNapoleone Ferrara
Oncology|November 23, 2005
VEGF as a therapeutic target in cancerNapoleone Ferrara
Nature Medicine|October 9, 2010
Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapyNapoleone Ferrara
EXS|December 25, 2004
The role of VEGF in the regulation of physiological and pathological angiogenesisNapoleone Ferrara
The Oncologist|June 5, 2004
Vascular endothelial growth factor as a target for anticancer therapyNapoleone Ferrara
European Cytokine Network|February 20, 2010
VEGF-A: a critical regulator of blood vessel growthNapoleone Ferrara
Cancer Research|September 3, 2016
Commentary on "Humanization of an Anti-VEGF Monoclonal Antibody for the Therapy of Solid Tumors and Other Disorders"Napoleone Ferrara
Cytokine & Growth Factor Reviews|December 17, 2009
Pathways mediating VEGF-independent tumor angiogenesisNapoleone Ferrara
Pageof 20